BrightInsight Stock

HealthTech

BrightInsight has developed a digital health platform that streamlines the optimization of regulated medications, devices, and software via integrated data and actionable insight. The platform employs software and services to gather, transmit, and analyze data from FDA-regulated and CE-marked medical devices, combination products, and software as a medical device. It adheres to security, privacy, and regulatory requirements. This enables biopharma and med-tech firms to expedite their market entry, decrease implementation and scaling costs across products, and expand into global markets.